M&A Deal Summary

Catalent Acquires Skeletal Cell Therapy Support SA

On October 29, 2020, Catalent acquired life science company Skeletal Cell Therapy Support SA from Bone Therapeutics for 12M EUR

Acquisition Highlights
  • This is Catalent’s 8th transaction in the Life Science sector.
  • This is Catalent’s 5th largest (disclosed) transaction.
  • This is Catalent’s 2nd transaction in Belgium.

M&A Deal Summary
Date 2020-10-29
Target Skeletal Cell Therapy Support SA
Sector Life Science
Buyer(s) Catalent
Sellers(s) Bone Therapeutics
Deal Type Divestiture
Deal Value 12M EUR

Target

Skeletal Cell Therapy Support SA

Charleroi, Belgium
Skeletal Cell Therapy Support SA owns and operates a purpose-built CGxP facility of approximately 41,000 square-foot (3,800 square-meter), including its related quality control and product development laboratories, warehouse, grade C, and B cleanrooms and equipment as well as land for further development. Skeletal Cell Therapy Support is based in Charleroi, Belgium.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Catalent

Somerset, New Jersey, United States

website

Category Company
Founded 2007
Sector Life Science
Revenue 4.3B USD (2023)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

DEAL STATS #
Overall 12 of 16
Sector (Life Science) 8 of 10
Type (Divestiture) 4 of 6
Country (Belgium) 2 of 3
Year (2020) 3 of 3
Size (of disclosed) 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-21 Teva Takeda Pharma - Clinical Packaging Facility

Minakuchi, Japan

Teva Takeda Pharma Ltd. - Clinical Packaging Facility is a clinical GMP manufacturing and distribution hub that supports clinical studies. The 60,000-square-foot facility provides demand-led supply services, primary and secondary packaging capabilities, a range of temperature options for storage and distribution, as well as clinical returns and destruction services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-13 Acorda Therapeutics - Manufacturing & Packaging Operations

Chelsea, Massachusetts, United States

Acorda Therapeutics' Manufacturing & Packaging Operations provides spray drying capacity, including GEA NIRO® PSD-1, PSD-4, and PSD-7 spray drying unit.

Buy -

Seller(S) 1

SELLER

Bone Therapeutics

Gosselies, Belgium

website

Category Company
Founded 2006
Sector Life Science
Employees30
Revenue 1M EUR (2020)
DESCRIPTION

Bone Therapeutics is an advanced biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention. Bone Therapeutics are creating a new and unique treatment approach using differentiated bone-forming cells administered via a minimally invasive procedure. Bone Therapeutics was founded in 2006 and is headquarters in Gosselies, Belgium.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Belgium) 1 of 1
Year (2020) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-10 Medsenic

Strasbourg, France

Medsenic is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide treatment for patients with autoimmune diseases. Medsenic was formed in 2010 and is based in Strasbourg, France.

Buy -
Mergr

Product

Company

Legal